Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations.
about
Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patientsExtracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patientsExtracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patientsPhysical function and quality of life in patients with chronic GvHD: a summary of preclinical and clinical studies and a call for exercise intervention trials in patientsThe Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical OverviewThe Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host DiseaseCombined meta-analysis of systemic effects of allogeneic stem cell transplantation and systemic sclerosis.Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease.Therapeutic Effects of a NEDD8-Activating Enzyme Inhibitor, Pevonedistat, on Sclerodermatous Graft-versus-Host Disease in Mice.Chronic graft-versus-host disease (GVHD) in children.Administration of anti-CD20 mAb is highly effective in preventing but ineffective in treating chronic graft-versus-host disease while preserving strong graft-versus-leukemia effectsIdentification of stem cell transcriptional programs normally expressed in embryonic and neural stem cells in alloreactive CD8+ T cells mediating graft-versus-host diseaseHigh levels of B-cell activating factor in patients with active chronic graft-versus-host disease.Treatment of chronic graft-versus-host disease with bortezomibSTAT3 signaling in CD4+ T cells is critical for the pathogenesis of chronic sclerodermatous graft-versus-host disease in a murine modelB cells and transplantation: an educational resource.Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II studyThymic T-cell development in allogeneic stem cell transplantationThe pathophysiology of chronic graft-versus-host disease: the unveiling of an enigmaRecipient B cells are not required for graft-versus-host disease induction.Aberrant B-cell homeostasis in chronic GVHDFlagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunityInhibition of BTK and ITK with Ibrutinib Is Effective in the Prevention of Chronic Graft-versus-Host Disease in MiceClinical applications for biomarkers of acute and chronic graft-versus-host disease.Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliteransRegulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes.Emergence of T cells that recognize nonpolymorphic antigens during graft-versus- host diseaseBiomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group.Understanding chronic GVHD from different anglesMurine models of chronic graft-versus-host disease: insights and unresolved issues.Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease.In vivo-activated CD103+CD4+ regulatory T cells ameliorate ongoing chronic graft-versus-host diseaseAntibodies are back for thymic attack in cGVHD.Antibodies from donor B cells perpetuate cutaneous chronic graft-versus-host disease in mice.IL-21 accelerates xenogeneic graft-versus-host disease correlated with increased B-cell proliferation.Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation?Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease.Thymic damage, impaired negative selection, and development of chronic graft-versus-host disease caused by donor CD4+ and CD8+ T cells.Donor B cells in transplants augment clonal expansion and survival of pathogenic CD4+ T cells that mediate autoimmune-like chronic graft-versus-host disease.Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease
P2860
Q24187102-A13E76B5-F59A-479D-A2E1-398CA9D444E7Q24200272-8BF8CA8F-30D6-4369-B81C-E495DB243345Q24202963-014412AC-E329-4306-8774-BCDEAC34B8FFQ26787230-A05CB8C5-8ABF-42B5-B17D-0117DAF8CB67Q28066083-3616CEF8-7B62-4CB6-80DA-3D7742F94AEEQ28076264-FF830994-7C0D-4189-A7E2-9193C11EC9C1Q33614372-C6C4E3EF-6641-4069-839C-0DA964D39EECQ33725411-825E86F0-0D33-46E0-9563-D01A14013780Q33792598-0156C8DC-812A-46C6-BACA-FF63E382B22DQ33857680-36192BD3-3264-4229-8BBE-0A3B201D54F4Q33905411-FF494228-8793-4AB4-A81A-D77C9B976E94Q34033248-3F5DA704-4933-4619-9D68-88594C3DEDA8Q34135089-99C4FE22-B84F-4C90-B30D-A5F7FCD12730Q34137032-A1EDB318-C2A8-42DB-A9F4-24F3292F36BDQ34139886-7AD763C7-F6B6-448E-917C-AF4646EBD94BQ34152189-70BB8C71-44FC-4A8B-A474-0F2B7DE16BD0Q34255166-1533918E-0EF4-47A2-8B99-7E44CDE29478Q35083246-9A1F60A7-ED5F-451F-9CEA-791DB5158BFBQ35084404-2E867105-79CC-41ED-BE93-D97CD9462749Q35104223-8701C87C-1B9E-46B7-9825-7F281E223551Q35171251-FFBBC4F6-6C1F-43F3-B7CC-B108E07CC169Q35691842-1CEC608E-586D-40AE-A2C8-07C0773E8440Q35766798-F15FBA13-1521-406A-B08E-C1316FD9FD57Q35767289-0FE3FEAC-15F6-4996-9C66-5AF26C405ECAQ35776453-43DE9DA7-78A1-4874-BDFE-5D33A32A4BBAQ36056986-2740FA5D-0340-4911-A536-42CBC1162B75Q36058558-A61FA9B6-5A0A-4450-AA29-E6A5DE088150Q36491894-38944212-09F9-4E0E-9620-3F6D85B98B09Q36551588-5F375FF1-5625-4E9B-9719-2D7E57886F56Q36645730-8D71C535-E800-480D-A336-E094AB9EDF50Q36843812-65DD1C2C-6BB5-4BC5-B856-B8D2BBEA4ED3Q36843821-B256A116-03AF-4966-A55B-66FE4C01F028Q36876960-9377C533-2D4F-4039-B37F-8B9EFAD5A8CDQ36876981-F54684FF-B156-441A-8378-493A8ABFF1B0Q36923019-B9D4C4CF-B21D-454C-9CD7-B6CC61A577AAQ37035815-46C2DD23-A719-413E-A1DB-5B3E6C06A1FEQ37064425-C8290F74-0B0F-490B-AAF1-E2A6F1DD438BQ37104254-87E36A43-AB22-43D2-8780-981DF405EE94Q37104281-9BC64697-9265-4774-BAE5-F6BCA8A901F1Q37162874-3ED97FE3-BE8D-41DB-B630-52CF25CC30EB
P2860
Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Donor CD4+ T and B cells in tr ...... ith autoimmune manifestations.
@en
Donor CD4+ T and B cells in tr ...... ith autoimmune manifestations.
@nl
type
label
Donor CD4+ T and B cells in tr ...... ith autoimmune manifestations.
@en
Donor CD4+ T and B cells in tr ...... ith autoimmune manifestations.
@nl
prefLabel
Donor CD4+ T and B cells in tr ...... ith autoimmune manifestations.
@en
Donor CD4+ T and B cells in tr ...... ith autoimmune manifestations.
@nl
P2093
P1433
P1476
Donor CD4+ T and B cells in tr ...... ith autoimmune manifestations.
@en
P2093
Chunyan Zhang
Fouad Kandeel
Ivan Todorov
Samuel Strober
Stephen Forman
Yinping Liu
Zhifang Zhang
P304
P356
10.1182/BLOOD-2005-09-3623
P407
P577
2005-12-13T00:00:00Z